Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Gynecologic Oncology|November 1, 1991
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patientsR D Alvarez, M E Potter, S J Soong, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 1, 1995
Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretionP A Crowley-Nowick, M Bell, R P Edwards, et al.Journal of Lower Genital Tract Disease|May 8, 2015
Histopathological variables predicting high-grade squamous intraepithelial lesions after large-loop excision of the transformation zoneM N Barnes, M W Robertson, R W Naumann, et al.American Journal of Obstetrics and Gynecology|April 1, 1982
Urinary diversion in patients undergoing pelvic exenterationJ W Orr, H M Shingleton, K D Hatch, et al.Gynecologic Oncology|March 26, 1998
Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimensP Y Roland, M N Barnes, S Niwas, et al.Journal of Clinical Immunology|May 1, 1995
CD8+ T lymphocytes are recruited to neoplastic cervixM C Bell, R P Edwards, E E Partridge, et al.The New England Journal of Medicine|January 4, 1996
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerW P McGuire, W J Hoskins, M F Brady, et al.Seminars in Oncology|February 1, 1997
Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group studyW P McGuire, W J Hoskins, M F Brady, et al.Seminars in Oncology|October 1, 1996
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)W P McGuire, W J Hoskins, M F Brady, et al.Surgery, Gynecology & Obstetrics|February 11, 1992
Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometriumC H Dyas, T K Simmons, C N Ellis, et al.Pageof 7